![Medicine / Alcohols / Amines / Overactive bladder / Incontinence / Oxybutynin / Darifenacin / Urinary incontinence / Fesoterodine / Chemistry / Muscarinic antagonists / Organic chemistry Medicine / Alcohols / Amines / Overactive bladder / Incontinence / Oxybutynin / Darifenacin / Urinary incontinence / Fesoterodine / Chemistry / Muscarinic antagonists / Organic chemistry](https://www.pdfsearch.io/img/c801b7185ddbe9986ff7e57d117a0f9e.jpg)
| Open Document File Size: 784,92 KBShare Result on Facebook
Company Merck / / Event FDA Phase / / IndustryTerm receptor agonist product / anti-muscarinic products / / MedicalCondition overactive bladder / Diabetes Bladder cancer Urinary tract infection Pregnancy Prostate disease / urgency urinary incontinence / urge urinary incontinence / / Organization FDA / Reproductive and Urologic Products Nonprescription Drugs Advisory Committee / Division of Reproductive / / Person Donald McNellis / / Position Director / Division of Nonprescription Clinical Evaluation November / / Product Oxytrol / Tolterodine / Rx / Oxybutynin tablets / Oxytrol® / Transdermal Oxybutynin Patch / /
SocialTag |